The announcement of a class action lawsuit against Maravai LifeSciences Holdings, Inc. is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for investors to join the lawsuit is May 5, 2025, which may keep the stock under pressure until then.